Tolerance Bio has finalized a high-stakes licensing agreement with Tanabe Pharma, acquiring exclusive worldwide commercialization rights—excluding Japan—for TLB-33, a clinical-stage…
Read More
WuXi XDC and Ona Therapeutics Expand Partnership Through Exclusive Global Licensing Agreement for Advanced Antibody-Drug Conjugate Platform
In a significant expansion of their ongoing strategic partnership, WuXi XDC Cayman has entered into an exclusive global licensing agreement…
Read More
AI and Machine Learning Poised to Revolutionize Antibody Therapeutics, Experts Declare as Landmark Journal Collection Concludes
The landscape of antibody therapeutic development is undergoing a profound transformation, driven by the accelerating integration of artificial intelligence (AI)…
Read More
The biotech bi-weekly: partnerships facilitating antibody discovery and AI drug development
The past two weeks have witnessed a significant acceleration in the biopharmaceutical landscape, marked by a flurry of strategic partnerships…
Read More
Professor Peter Tessier Pioneers AI-Driven Solutions for Antibody Deliverability Challenges
In a significant advancement for pharmaceutical sciences, Professor Peter Tessier, the esteemed Albert M. Mattocks Professor of Pharmaceutical Sciences and…
Read More
Oxford Professor Unveils AI Software Humatch for Rapid, Gene-Specific Antibody Humanization, Revolutionizing Therapeutic Development
Oxford, UK – In a significant stride for pharmaceutical innovation, Professor Charlotte Dean, a leading figure in Structural Bioinformatics at…
Read More
Amazon Bio Discovery cut MSK antibody design from a year to weeks, AWS says.
Amazon Web Services (AWS) has announced the launch of Amazon Bio Discovery, a groundbreaking application designed to revolutionize the speed…
Read More
Amazon Bio Discovery cut MSK antibody design from a year to weeks, AWS says
Amazon Web Services (AWS) has announced the launch of Amazon Bio Discovery, a groundbreaking application poised to revolutionize drug discovery…
Read More
Scientists Pioneer World’s First Human Antibody Treatment for Measles, Offering Critical Defense Amid Global Resurgence
In a groundbreaking development that promises to reshape the global fight against measles, scientists at the La Jolla Institute for…
Read More
Amazon Bio Discovery cut MSK antibody design from a year to weeks, AWS says
Amazon Web Services (AWS) today unveiled Amazon Bio Discovery, a groundbreaking application designed to drastically accelerate the drug discovery process…
Read More
